IBD LIVE
The Inflammatory Bowel Disease Live Interinstitutional and
Interdisciplinary Videoconference Education (IBD LIVE) Series
Miguel D. Regueiro, MD,
1
Julia B. Greer, MD, MPH,
1
David G. Binion, MD,
1
Wolfgang H. Schraut, MD,
2
Alka Goyal, MD,
3
David J. Keljo, MD,
3
Raymond K. Cross, MD, MS,
4
Emmanuelle D. Williams, MD,
5
Hans H. Herfarth, MD, PhD,
6
Corey A. Siegel, MD,
7
Ioannis Oikonomou, MD,
8
Myron H. Brand, MD,
8,9
Douglas J. Hartman, MD,
10
Mitchell E. Tublin, MD,
11
Peter L. Davis, MD,
11
Leonard Baidoo, MD,
1
Eva Szigethy, MD, PhD,
12,13,14
and Andrew R. Watson, MD, MLitt
15
on behalf of the IBD LIVE Physician Group
Background: Managing patients with inflammatory bowel disease requires multidisciplinary coordination. Technological advances have enhanced
access to care for patients and improved physician interactions. The primary aim of our project was to convene diverse institutions and specialties through
a multisite virtual conferencing platform to discuss complex patient management.
Methods: The case conference is designed to include multiple institutions to exchange ideas, review evidence-based data, and provide input on the
management of patients with Crohn’s disease and ulcerative colitis. Technology is supplied and coordinated by an information technology specialist and
Chorus Call, Inc., an international teleconferencing service provider. The Inflammatory Bowel Disease Live Interinstitutional Interdisciplinary Video-
conference Education (IBD LIVE) initiative is accredited by the University of Pittsburgh Medical Center (UPMC) Center for Continuing Education in the
Health Sciences for 1 AMA PRA Category 1 Credit per weekly session.
Results: IBD LIVE began in 2009 comprising only adult gastroenterology and pediatric gastroenterology from UPMC Presbyterian and Children’s
Hospitals. Participation steadily increased from 5 sites in 2010 to 11 sites in 2014. Maximum attendance for a single conference was 73 participants with
a median of 48. The Continuing Medical Education scores (1 ¼ worst to 5 ¼ best) have a high median overall score (4.6, range 3.2–5.0) with positive
responses with regard to the degree to which the conference changed practice.
Conclusions: IBD LIVE has been successful and continues to grow. Implementation of the Crohn’s and Colitis Foundation of America Virtual
Preceptor Program using the IBD LIVE platform will provide expanded national physician access to this professional education activity.
(Inflamm Bowel Dis 2014;20:1687–1695)
T
he management of patients with Crohn’s disease and ulcera-
tive colitis, collectively known as inflammatory bowel disease
(IBD), has relied on a multidisciplinary approach to integrate best
practices and expert opinions.
1
Traditionally, decisions on the
care of patients with IBD have been based on consultation with
subspecialists within a single center or hospital system. Primary
care physicians, gastroenterologists, and surgeons would ordinar-
ily provide the majority of care for patients with IBD. In 2014,
Received for publication July 10, 2014; Accepted July 10, 2014.
From the
1
Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine Center, Pittsburgh, Pennsylvania;
2
Department of Surgery, Division of Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
3
Department of Pediatrics, Division of Pediatric
Gastroenterology, Hepatology and Nutrition, Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania;
4
Department of Medicine,
Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Baltimore, Maryland;
5
Department of Medicine, Division of Gastroenterology and Hepatol-
ogy, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania;
6
Department of Medicine, Division of Gastroenterology and Hepatology, University of North
Carolina School of Medicine, Chapel Hill, North Carolina;
7
Department of Medicine, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center,
Lebanon, New Hampshire;
8
Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut;
9
Gastroenterology Consultants
of Connecticut, New Haven, Connecticut;
10
Department of Pathology, Division of Anatomic Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
11
Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Departments of
12
Psychiatry,
13
Pediatrics, and
14
Medicine, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and
15
Department of Surgery, Division of Colon and Rectal Surgery, University of Pittsburgh School of Medicine,
Pittsburgh, Pennsylvania.
Supported by the Sigal Family Research and Education Inflammatory Bowel Disease Fund.
The authors have no conflicts of interest to disclose.
Additional collaborators from the IBD LIVE Physician group are given in the Appendix.
Reprints: Miguel D. Regueiro, MD, Division of Gastroenterology, Hepatology and Nutrition, Inflammatory Bowel Disease Center, University of Pittsburgh Medical
Center, PUH-C Wing Mezzanine Level, 200 Lothrop Street, Pittsburgh, PA 15213 (e-mail: mdr7@pitt.edu).
Copyright © 2014 Crohn’s & Colitis Foundation of America, Inc.
DOI 10.1097/MIB.0000000000000187
Published online 27 August 2014.
Inflamm Bowel Dis Volume 20, Number 10, October 2014 www.ibdjournal.org
|
1687
Downloaded from https://academic.oup.com/ibdjournal/article/20/10/1687/4578811 by guest on 22 October 2023